Activities
VICH Steering Committee
Next meeting
43rd SC meeting (& 7th VICH Public Conference)
10 – 15 November 2024 at the EMA Offices (Amsterdam, The Netherlands)
VICH Outreach forum
Next meeting:
17th VICH Forum meeting
11 & 12 November 2024 at the EMA Offices (Amsterdam, The Netherlands)
Public Conference
7th VICH PUBLIC CONFERENCE
November 2024 at the EMA Offices (Amsterdam, The Netherlands)
REGISTRATION IS CLOSED
Public Consultations
Concept papers
No items found
Draft Guidelines for Public Consultation
- Efficacy of anthelmintics: general requirements (Revision 1)
VICH GL 7(R1)(Anthelmintics General) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for bovines
VICH GL 12(R1)(Anthelmintics Bovine) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for ovines (Revision 1)
VICH GL 13(R1)(Anthelmintics Ovine) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for caprines
VICH GL 14(R1)(Anthelmintics Caprine) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for equines (Revision 1)
VICH GL 15(R1)(Anthelmintics Equine) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for porcines (Revision 1)
VICH GL 16(R1)(Anthelmintics Porcines) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Impurities: Residual Solvents in new Veterinary Medicinal Products, Active Substances and Excipients (Revision 2)
VICH GL 18(R2)(Quality – Impurities: Residual Solvents) – December 2021 – Released at Step 4 for a 6-months consultation period until June 10, 2022
- Efficacy of anthelmintics: specific recommendations for canines (Revision 1)
VICH GL 19(R1)(Anthelmintics Canine) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for felines (Revision 1)
VICH GL 20(R1)(Anthelmintics Feline) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- Efficacy of anthelmintics: specific recommendations for poultry (Revision 1)
VICH GL 21(R1)(Anthelmintics Poultry) – May 2022 – Released at Step 4 for a 6-months consultation period until November 1, 2022
- GMP for API: Good Manufacturing Practice for Active Pharmaceutical Ingredients used in Veterinary Medicinal Products
VICH GL 60(Quality) – September 2023 – Released at Step 4 for a 6-months consultation period until March 2024
- Reproduction: Studies to evaluate the safety of residues of veterinary drug in human food: reproduction studies
VICH GL 22(R)(Safety) – January 2024 – Released at Step 4 for a 6-months consultation period until July 31, 2024
- Pharmaceutical Development: Pharmaceutical Development for Veterinary Medicinal Products
VICH GL 61Quality – February 2024 – Released at Step 4 for a 6-months consultation period until August 15, 2024
- Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing
VICH GL 23(R2)(Safety) – May 2024 – Released at Step 4 for a 6-months consultation period until November 30, 2024
Comments Received During Public Consultation
- VICH GL18(R2) – Comments at Step 4
(Quality – Impurities) - VICH GL59 – Comments at Step 4
(Biologicals – LABST Veterinary Vaccines) - VICH GL56 – Comments at Step 4
(MRK – Honey) - VICH GL54 – Comments at Step 4
(Safety) - VICH GL53 – Comments at Step 4
(EFF) - VICH GL52 – Comments at Step 4
(Bioequivalence) - VICH GL51 – Comments at Step 4
(Pharmaceuticals – Quality: Stability Data) - VICH GL50 – Comments at Step 4
(Biologicals: TABST)